Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print

Industry News

Related Searches:

Filter by:

DSM Expands Service Offerings
November 6, 2007
DSM Pharmaceuticals Inc. has expanded its service offerings to include formulation development and clinical trial manufacturing for solid dosage form products. “This expansion of services will have significant value-added benefits to our…   Read More »
Bilcare Completes Phase I Of Expansion Program
November 5, 2007
Bilcare Global Clinical Supplies opened five state-of-the-art primary packaging rooms at its Phoenixville, PA facility as part of the company's expansion and modernization program. During 4Q2007 the company will complete the next phase of upgrades wi…   Read More »
SGS Gets European Outsourcing Award
November 5, 2007
SGS received the 2007 European Outsourcing Award for Best Contract Analytical Project. The award was sponsored by Via Media, Ltd., a UK-based company that sponsors ten award categories ranging from Best New Product to Best Merger/Acquisition. The awa…   Read More »
FDA Inspects Hovione TTC In NJ
November 2, 2007
Hovione's Technology Transfer Center (TTC) in New Jersey has passed successfully a pre-approval inspection by FDA. The three-day inspection was carried out by Ms. Joy R. Kozlowski-Klena, a compliance officer at FDA's Center for Drug Evaluation and Re…   Read More »
Laureate To Manufacture For ImmunoGen
November 2, 2007
Laureate Pharma, Inc. has entered into a contract manufacturing agreement with ImmunoGen, Inc. to manufacture the huC242 antibody used in production of ImmunoGen's huC242-DM4 Tumor-Activated Prodrug (TAP) compound, now in Phase II clinical testing. T…   Read More »
Emisphere To Move HQ
October 31, 2007
Emisphere Technologies, Inc. will move its corporate headquarters from Tarrytown, NY to Cedar Knolls, NJ. Emisphere will retain its scientific staff and laboratory facilities in Tarrytown. "This move allows us to better serve all of our cust…   Read More »
MDS Expands Central Labs In China
October 30, 2007
MDS Pharma Services has moved its central lab services to a new, larger facility in Beijing to meet growing demands from pharmaceutical and biotech companies conducting clinical trials in China. With almost 25,000 sq. ft., the new facility offers…   Read More »
CAT Folds Into MedImmune
October 29, 2007
Cambridge Antibody Technology (CAT), owned by AstraZeneca, will be folded into MedImmune and will adopt its name. The new MedImmune business unit will unite the resources and expertise from CAT, the pre-existing MedImmune and other biologics activiti…   Read More »
Gibraltar Completes First Phase Of Expansion
October 29, 2007
Gibraltar Laboratories Inc., (GBL) a life science CGMP/ISO 17025 testing and consulting firm, has completed the first phase of a 14,000-sq.-ft. expansion of its laboratory facilities. The company currently owns and occupies 12,000 square feet at 1…   Read More »
Akorn Opens R&D Center
October 25, 2007
Akorn, Inc. has signed a 10-year operating lease for a newly constructed product development facility located in Gurnee, IL. This site, a Center for Excellence, will centralize Akorn's new product development activities,  consolidating developme…   Read More »
PPD Opens New International Offices
October 24, 2007
PPD, Inc. has opened offices in Sydney, Australia; Copenhagen, Denmark; Lisbon, Portugal; and Lima, Peru. The company says the moves reflect "continued expansion of its Phase II-IV services in key therapeutic areas." The four new offices…   Read More »
Almac Invests $100 Million In NA HQ
October 23, 2007
Almac, a provider of R&D and manufacturing services based in Craigavon, Northern Ireland, announced plans to invest $100 million to build its North American headquarters. The new facility will add approximately 260 jobs within three years. Sai…   Read More »
King Pharma Changes Strategy, Lays Off 20%
October 19, 2007
King Pharmaceuticals plans to lay off 20% of its workforce in an effort to speed up its strategic focus in neuroscience and hospital/acute care. The company estimates that the firings and other reductions in general and administrative expenses will s…   Read More »
Baxter Adds To Specialty Therapeutics Portfolio
October 16, 2007
Baxter International, Inc. has signed an agreement with Kaketsuken, the Chemo-Sero-Therapeutic Research Institute based in Kumamoto Japan, for the worldwide rights to develop, manufacture and market the recombinant protein ADAMTS13 for the treatment…   Read More »
Biogen Idec Considers Selling Out
October 15, 2007
Biogen Idec's board of directors has authorized management to evaluate the potential sale of the company. BI's business outlook, released on September 6, expressed the company's quest to generate strong operating and financial performance by the…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: